FDA issued a Warning Letter to Amgen, Inc. on 1/27/2014 as a result of this inspection.
483 Amgen Jun 2013

483 Amgen Jun 2013

Donna Besone FDA$119.00 - Available Now

FDA investigators audited the Amgen - Thousand Oaks, CA, United States facility and issued 3 inspectional observations (via FDA 483) on 17 Jun 2013.

Product details

  • Category: Medical Devices & Rad Health
  • Number of Observations: 3
  • Inspection end: 17 Jun 2013
  • Location: Thousand Oaks, United States
  • FEI: 2026154
Add To Cart